docosapentaenoic-acid and Hyperlipidemias

docosapentaenoic-acid has been researched along with Hyperlipidemias* in 2 studies

Trials

1 trial(s) available for docosapentaenoic-acid and Hyperlipidemias

ArticleYear
ω-3 polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity.
    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2012, Volume: 27, Issue:4

    To evaluate the influence of ω-3 polyunsaturated fatty acid (ω-3 PUFA) supplementation on body composition, insulin resistance, and lipemia of women with type 2 diabetes, the authors evaluated 41 women (60.64 ± 7.82 years) with high blood pressure and diabetes mellitus in a randomized and single-blind longitudinal intervention study. The women were divided into 3 groups: GA (2.5 g/d fish oil), GB (1.5 g/d fish oil), and GC (control). The capsules with the supplement contained 21.9% of eicosapentaenoic acid and 14.1% of docosapentaenoic acid. Biochemical (glucose, glycated hemoglobin, total and fractional cholesterol, triglycerides, and insulin) and anthropometric (body mass, stature, waist circumference [WC], and body composition) evaluations were performed before and after the 30 days of intervention. Homeostasis model assessment-insulin resistance and the Quantitative Insulin Sensitivity Check Index were used to evaluate the insulin resistance and insulin sensitivity (IS), respectively. GB presented a greater loss of body mass and WC (P < .05), greater frequency of glycemic and total cholesterol reduction, and an increase of high-density lipoprotein cholesterol compared with GA. Thus, a high dose of ω-3 PUFA can reduce IS. A lower dose of ω-3 PUFA positively influenced body composition and lipid metabolism.

    Topics: Aged; Blood Glucose; Body Composition; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Dietary Supplements; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Fish Oils; Glycated Hemoglobin; Humans; Hyperlipidemias; Insulin; Insulin Resistance; Middle Aged; Obesity; Single-Blind Method; Triglycerides; Waist Circumference

2012

Other Studies

1 other study(ies) available for docosapentaenoic-acid and Hyperlipidemias

ArticleYear
[Evaluation of the hemorheologic effects of the eicosapentaenoic and docosahexaenoic acids in asymptomatic dyslipidemic and arteriopathic subjects].
    Minerva medica, 1987, Aug-15, Volume: 78, Issue:15

    The low incidence of cardiovascular disease in Greenlandic Eskimos is related to the effect of dietary omega-3 polyunsaturated fatty acids. An important anti-atherosclerotic mechanism of compounds such as EPA and DHA consist in the modulation of cell membrane and properties. A change in the lipid composition of the diet and a dietary supplementation with EPA and DHA contribute to suggested potential therapeutic effect on peripheral vascular disease. The Authors report the results obtained by Doppler C.W. ultrasound in hyperlipidemic-arteriopathic patients.

    Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Blood Viscosity; Cholesterol; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides

1987